Concomitant-acquired long QT and Brugada syndromes associated with indapamide-induced hypokalemia and hyponatremia

PACE - Pacing and Clinical Electrophysiology

Volumn 31, Issue 6, 2008, Pages 772-775

  Mok, Ngai Shing ^a,b   Tong, Chak Kwan ^a   Yuen, Ho Chuen ^a  

^a PRINCESS MARGARET HOSPITAL   (Hong Kong)

^b NONE   (Hong Kong)

Author keywords

Acquired long QT syndrome; Brugada syndrome; Hypokalemia; Hyponatremia; Indapamide

Indexed keywords

FLECAINIDE; INDAPAMIDE;

ADULT; ARTICLE; BRUGADA SYNDROME; CASE REPORT; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROLYTE DISTURBANCE; GENE; GENE MUTATION; HUMAN; HYPERTENSION; HYPOKALEMIA; HYPONATREMIA; LONG QT SYNDROME; MALE; PATHOGENESIS; RISK FACTOR; SCN5A GENE;

ANTIHYPERTENSIVE AGENTS; BRUGADA SYNDROME; HUMANS; HYPOKALEMIA; HYPONATREMIA; INDAPAMIDE; LONG QT SYNDROME; MALE; MIDDLE AGED;

EID: 44349134474     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2008.01085.x     Document Type: Article

References (10)

1. Chan TY. Indapamide-induced severe hyponatraemia and hypokalaemia. Ann Pharmacother 1995 29 : 1124 1128.
2. Letsas KP, Alexanian IP, Pappas LK, Kounas SP, Efremidis M, Sideris A, Kardaras F. QT interval prolongation and torsade de pointes associated with indapamide. Int J Cardiol 2006 112 : 373 374.
3. Araki T, Konno T, Itoh H, Ino H, Shimizu M. Brugada syndrome with ventricular tachycardia and fibrillation related to hypokalemia. Circ J 2003 67 : 93 95.
4. Nademanee K, Veerakul G, Schwab M. Predisposing factors in the Brugada syndrome. In : Antzelevitch C, Brugada P (eds The Brugada Syndrome. Elmsford, New York, Blackwell Publishing, 2004, pp. 157 165.
5. Viskin S. Justo D, Halkin A, Zeltser D. Long QT syndrome caused by noncardiac drugs. Prog Cardiovasc Dis 2003 45 : 415 427.
6. Hirota M, Ohtani H, Hanada E, Sato H, Kotaki H, Uemura H, Nakaya H, et al. Influence of extracellular K+ concentrations on quinidine-induced K+ current inhibition in rat ventricular myocytes. J Pharm Pharmacol 2000 52 : 99 105.
7. Antzelevitch C. The Brugada syndrome. Diagnostic criteria and cellular mechanisms. Eur Heart J 2001 22 : 356 363.
8. Paulussen AD, Gilissen RA, Armstrong M, Doevendans PA, Verhasselt P, Smeets HJ, Schulz-Bahr E, et al. Genetic variations of KCNQ1, KCNH2, SCN5A, KCNE1, and KCNE2 in drug-induced long QT syndrome patients. J Mol Med 2004 82 : 182 188.
9. Alings M, Wilde A. 'Brugada' syndrome: Clinical data and suggested pathophysiological mechanism. Circulation 1999 99 : 666 673.
10. Brugada P, Bartholomay E, Mont L, Brugada R, Brugada J. Treatment of Brugada syndrome with an implantable cardioverter defibrillator. In : Antzelevitch C, Brugada P (eds The Brugada Syndrome. Elmsford, New York, Blackwell Publishing, 2004, pp. 194 201.